The IP Wave31

Check out the latest posts
Shivani Singh

Between Patents and Patients: Humira Case Study

Humira's wide range of indications has earned it the nickname "Swiss army knife" of pharmaceuticals. The success of Humira can be attributed not only to its therapeutic benefits but also to its patent and pricing practices. Over the past two decades, AbbVie has increased the drug's price 30 times.

You’ve successfully subscribed to Sanrachna Foundation
Welcome back! You’ve successfully signed in.
Great! You’ve successfully signed up.
Success! Your email is updated.
Your link has expired
Success! Check your email for magic link to sign-in.
Please enter at least 3 characters 0 Results for your search